The first Global Health Connector Partnership Summit will take place in Boston M.A during the HLTH 2021 Conference and Expo hybrid event, 17 - 20 October 2021.

In 2020 the Digital Health Society (DHS) and The European Institute for Innovation through Health Data (i~HD) collaborated on health data and ran two Round Tables with a range of stakeholders and created the Calls to Action. This summer they continued their collaboration for a Third Round Table on "Proposing a common basis for health […]

3rd Annual Summit (to be held virtually) In Europe 2021, health data has never had a higher public profile as citizens watch R numbers, infection rates and a variety of other pandemic and public health variables. The European Commission has kept busy with consultations and legislation proposals on the European Health Data Space, and the […]

Data will play a key role in our future. Sometimes called ‘the new oil’, they form a basis for research and innovation and for the development of new products, services and powerful technologies. Innovations arising from open data will improve our lives and boost economic growth. Would you like to contribute to the shift to […]

ECHAlliance is delighted to have partnered with ATA2022 Conference & Expo, the world’s largest telehealth innovation event for providers, technology developers, business professionals and leaders from across the healthcare sector, and organise our Global Health Connector Partnership (GHCP) Summit on Sunday 1st May from 9:30 to 11h EST Time.   Discussing the Summit theme “Globally […]

In tackling the pandemic, the EU has taken centre stage in areas of public health and healthcare that were previously the sole domain of national governments and brought into focus the ambition for a deeper European Health Union. However, bolder action is needed to achieve a European Health Union and to ensure that health and […]

The ECRD is recognised globally as the largest, patient-led rare disease policy event in which collaborative dialogue, learning and conversation takes place, forming the groundwork to shape goal-driven rare disease policies and allow for important and innovative discussions on a national and an international level to take place. Leading, inspiring and engaging all stakeholders to […]